S. Eschrich

Jacob G. Scott, S. Eschrich, J. Torres-Roca, 2018, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Radiosensitivity Differences Between Liver Metastases Based on Primary Histology Suggest Implications for Clinical Outcomes After Stereotactic Body Radiation Therapy.

S. Eschrich, J. Torres-Roca, B. Yue, 2016, International journal of radiation oncology, biology, physics.

Differences Between Colon Cancer Primaries and Metastases Using a Molecular Assay for Tumor Radiation Sensitivity Suggest Implications for Potential Oligometastatic SBRT Patient Selection.

S. Eschrich, J. Torres-Roca, T. Dilling, 2014, International journal of radiation oncology, biology, physics.

Volume doubling time and radiomic features predict tumor behavior of screen-detected lung cancers.

R. Gillies, S. Eschrich, Y. Balagurunathan, 2022, Cancer biomarkers : section A of Disease markers.

Empirically-Derived Synthetic Populations to Overcome Small Sample Sizes

T. Sellers, J. Heine, S. Eschrich, 2018, bioRxiv.

Personalized medicine for radiation therapy.

S. Eschrich, J. Torres-Roca, J. Caudell, 2013, Personalized medicine.

Transforming growth factor β-induced epithelial-to-mesenchymal signature predicts metastasis-free survival in non-small cell lung cancer

S. Eschrich, D. Shibata, W. D. Cress, 2019, Oncotarget.

Association Between Computed Tomographic Features and Kirsten Rat Sarcoma Viral Oncogene Mutations in Patients With Stage I Lung Adenocarcinoma and Their Prognostic Value.

Matthew B Schabath, Ying Liu, Zhaoxiang Ye, 2016, Clinical lung cancer.

Claudin-2 Expression Increases Tumorigenicity of Colon Cancer Cells: Role of Epidermal Growth Factor Receptor Activation

X. Chen, T. Yeatman, S. Eschrich, 2011, Oncogene.

Peritumoral and intratumoral radiomic features predict survival outcomes among patients diagnosed in lung cancer screening

R. Gillies, S. Eschrich, O. Stringfield, 2020, Scientific Reports.

RADIOMICS ON LUNG CANCER

P. Lambin, J. Heine, E. Moros, 2014 .

Tumor Radiosensitivity is Associated with Immune Activation in Solid Tumors

S. Eschrich, D. Coppola, A. Giuliano, 2018 .

Early2 factor (E2F) deregulation is a prognostic and predictive biomarker in lung adenocarcinoma

S. Eschrich, M. Schabath, R. Rosell, 2016, Oncotarget.

ZEB1 Mediates Acquired Resistance to the Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer

S. Eschrich, F. Tanaka, H. Uramoto, 2016, PloS one.

Mass spectrometry mapping of epidermal growth factor receptor phosphorylation related to oncogenic mutations and tyrosine kinase inhibitor sensitivity.

Richard Z. Liu, S. Eschrich, S. Altiok, 2011, Journal of proteome research.

LC-HRMS of derivatized urinary estrogens and estrogen metabolites in postmenopausal women.

S. Eschrich, K. Egan, J. Koomen, 2020, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

Methods for investigation of targeted kinase inhibitor therapy using chemical proteomics and phosphorylation profiling.

S. Eschrich, K. Smalley, E. Haura, 2010, Biochemical pharmacology.

Primary tumors from mucosal barrier organs drive unique eosinophil infiltration patterns and clinical associations

S. Eschrich, J. Torres-Roca, A. Munitz, 2020, Oncoimmunology.

The radiosensitivity of brain metastases based upon primary histology utilizing a multigene index of tumor radiosensitivity.

S. Eschrich, J. Torres-Roca, P. Johnstone, 2017, Neuro-oncology.

Abstract 3250: Survival of patients with incident lung cancer following screening by computed tomography in the National Lung Screening Trial

R. Gillies, S. Eschrich, P. Massion, 2014 .

Effects of long-term norepinephrine treatment on normal immortalized ovarian and fallopian tube cells

S. Eschrich, A. Monteiro, S. Yoder, 2021, Scientific Reports.

Quantification of peptides from immunoglobulin constant and variable regions by LC‐MRM MS for assessment of multiple myeloma patients

Richard Z. Liu, S. Eschrich, J. Teer, 2014, Proteomics. Clinical applications.

EPB41L5 is Associated With the Metastatic Potential of Low-grade Pancreatic Neuroendocrine Tumors

S. Eschrich, D. Coppola, M. Shahid, 2019, Cancer Genomics & Proteomics.

Metabolomics of primary cutaneous melanoma and matched adjacent extratumoral microenvironment

S. Eschrich, K. Smalley, J. Messina, 2020, PloS one.

Dissection of TBK1 signaling via phosphoproteomics in lung cancer cells

Bin Fang, John M. Koomen, Steven A. Eschrich, 2013, Proceedings of the National Academy of Sciences.

Differential association of STK11 and TP53 with KRAS mutation-associated gene expression, proliferation and immune surveillance in lung adenocarcinoma

Steven Eschrich, Dung-Tsa Chen, William J. Fulp, 2015, Oncogene.

Image Texture and Fourier Analysis in a Polar Spatial Frequency System: methods illustration

J. Heine, S. Eschrich, E. Fowler, 2020 .

GARD is a pan-cancer predictor of clinical outcome in radiation treated patients.

M. Kattan, S. Eschrich, J. Torres-Roca, 2020, medRxiv.

Optimizing Clinical Outcome and Toxicity in Lung Cancer Using a Genomic Marker of Radiosensitivity

Jacob G. Scott, M. Kattan, S. Eschrich, 2020 .

Personalizing Radiotherapy Prescription Dose Using Genomic Markers of Radiosensitivity and Normal Tissue Toxicity in Non-Small Cell Lung Cancer.

Jacob G. Scott, M. Kattan, S. Eschrich, 2019, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Use of the Total Cancer Care System to Enrich Screening for CD30-Positive Solid Tumors for Patient Enrollment Into a Brentuximab Vedotin Clinical Trial: A Pilot Study to Evaluate Feasibility

H. Dai, S. Eschrich, W. Dalton, 2017, JMIR research protocols.

Expression of CAS/CSE1L, the Cellular Apoptosis Susceptibility Protein, Correlates With Neoplastic Progression in Barrett’s Esophagus

S. Eschrich, D. Coppola, M. Malafa, 2016, Applied immunohistochemistry & molecular morphology : AIMM.

Inhibition of the FAD containing ER oxidoreductin 1 (Ero1) protein by EN-460 as a strategy for treatment of multiple myeloma.

S. Eschrich, W. Geldenhuys, A. Becker, 2019, Bioorganic & medicinal chemistry.

Monitoring a Nuclear Factor- (cid:1) B Signature of Drug Resistance in Multiple Myeloma*

S. Eschrich, Lili He, J. Cheng, 2011 .

Green tea catechins suppress the DNA synthesis marker MCM7 in the TRAMP model of prostate cancer

T. Yeatman, S. Eschrich, S. Enkemann, 2007, Molecular oncology.

An Introduction to the skewr Package

S. Eschrich, A. Berglund, Ryan M. Putney, 2015 .

Utilizing the Radiosensitivity Index (RSI) to Predict Pelvic Failure in Endometrial Cancer Treated with Adjuvant Radiotherapy

S. Eschrich, R. Wenham, J. Torres-Roca, 2019, International Journal of Radiation Oncology*Biology*Physics.

Exploiting convergent evolution to derive a pan-cancer cisplatin response gene expression signature

S. Eschrich, J. Torres-Roca, Dhawan, 2022 .

Ethnic and racial-specific differences in levels of centrosome-associated mitotic kinases, proliferative and epithelial-to-mesenchymal markers in breast cancers

S. Eschrich, S. Chellappan, H. Saavedra, 2022, Cell division.

Claudin-1 up-regulates the repressor ZEB-1 to inhibit E-cadherin expression in colon cancer cells.

X. Chen, T. Yeatman, S. Eschrich, 2011, Gastroenterology.

Pan-cancer prediction of radiotherapy benefit using genomic-adjusted radiation dose (GARD): a cohort-based pooled analysis.

Jacob G. Scott, M. Kattan, S. Eschrich, 2021, The Lancet. Oncology.

Procedure for stability analysis of gene selection from cross-site gene expression data

Lawrence O. Hall, Dmitry B. Goldgof, Steven Eschrich, 2011, 2011 IEEE International Conference on Systems, Man, and Cybernetics.

Slicing: A Distributed Learning Approach

Lawrence O. Hall, Steven A. Eschrich, S. Eschrich, 2006 .

Molecular profiling predicts colon cancer survival better than dukes staging

I. Yang, T. Yeatman, John Quackenbush, 2004, Annals of Surgical Oncology.

Knockdown of CSE1L Gene in Colorectal Cancer Reduces Tumorigenesis in Vitro.

S. Eschrich, D. Coppola, D. Shibata, 2016, The American journal of pathology.

Tumour radiosensitivity is associated with immune activation in solid tumours.

S. Eschrich, J. Foekens, D. Coppola, 2017, European journal of cancer.

The radiosensitivity index predicts for overall survival in glioblastoma

Steven Eschrich, William J Fulp, Prakash Chinnaiyan, 2015, Oncotarget.

The metabolomic signature of malignant glioma reflects accelerated anabolic metabolism.

Steven Eschrich, Xiaotao Qu, Prakash Chinnaiyan, 2012, Cancer research.

Monitoring a Nuclear Factor-κB Signature of Drug Resistance in Multiple Myeloma*

S. Eschrich, Lili He, J. Cheng, 2011, Molecular & Cellular Proteomics.

Regional Radiation Therapy Impacts Outcome for Node-Positive Cutaneous Melanoma.

V. Sondak, T. Strom, S. Eschrich, 2017, Journal of the National Comprehensive Cancer Network : JNCCN.

Gene expression–based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study

Igor Jurisica, Kerby Shedden, Steven Eschrich, 2008, Nature Medicine.

Harnessing Tumor Immune Ecosystem Dynamics to Personalize Radiation Therapy

S. Eschrich, J. Torres-Roca, J. Cleveland, 2020 .

Harnessing tumor immune ecosystem dynamics to personalize radiotherapy

S. Eschrich, J. Torres-Roca, J. Cleveland, 2020, bioRxiv.

Evolutionary computation with noise perturbation and cluster analysis to discover biomarker sets

J. David Schaffer, Ravi Mathur, John J. Heine, 2011, Complex Adaptive Systems.

Gene Expression Profiling of Colorectal Mucinous Adenocarcinomas

Quan P. Ly, Jonathan M. Hernandez, T. Yeatman, 2010, Diseases of the colon and rectum.

12-Chemokine Gene Signature Identifies Lymph Node-like Structures in Melanoma: Potential for Patient Selection for Immunotherapy?

V. Sondak, S. Eschrich, M. Schell, 2012, Scientific Reports.

BAD Phosphorylation Determines Ovarian Cancer Chemosensitivity and Patient Survival

S. Eschrich, A. Berchuck, J. Lancaster, 2011, Clinical Cancer Research.

A Pilot Proteogenomic Study with Data Integration Identifies MCT1 and GLUT1 as Prognostic Markers in Lung Adenocarcinoma

Bin Fang, Keiryn L. Bennett, John M. Koomen, 2015, PloS one.

Iterative rank-order normalization of gene expression microarray data

Anders Berglund, Steven Eschrich, David A. Fenstermacher, 2013, BMC Bioinformatics.

Integrating Biological Covariates into Gene Expression-Based Predictors of Radiation Sensitivity

S. Eschrich, J. Torres-Roca, Vidya P Kamath, 2017, International journal of genomics.

Quantification of beta-catenin signaling components in colon cancer cell lines, tissue sections, and microdissected tumor cells using reaction monitoring mass spectrometry.

Richard Z. Liu, T. Yeatman, M. Gruidl, 2010, Journal of proteome research.

Expanding Epigenomics to Archived FFPE Tissues: An Evaluation of DNA Repair Methodologies

S. Eschrich, D. Coppola, D. Shibata, 2014, Cancer Epidemiology, Biomarkers & Prevention.

Predictive Biomarkers and Personalized Medicine BAD Phosphorylation Determines Ovarian Cancer Chemosensitivity and Patient Survival

S. Eschrich, A. Berchuck, J. Lancaster, 2011 .

Category : Predictive Biomarkers and Personalized Medicine BAD phosphorylation determines ovarian cancer chemo-sensitivity and patient survival

S. Eschrich, A. Berchuck, J. Lancaster, 2011 .

Necdin, a Negative Growth Regulator, Is a Novel STAT3 Target Gene Down-Regulated in Human Cancer

S. Eschrich, R. Jove, Yihong Ma, 2011, PloS one.

GARD is a pan-cancer predictor of radiation therapy benefit

Jacob G. Scott, M. Kattan, S. Eschrich, 2020 .

Systems biology modeling of the radiation sensitivity network: a biomarker discovery platform.

Steven Eschrich, David Boulware, Ji-Hyun Lee, 2009, International journal of radiation oncology, biology, physics.

Prediction of radiation sensitivity using a gene expression classifier.

Steven Eschrich, Timothy Yeatman, T. Yeatman, 2005, Cancer research.

Persistent Activation of Stat3 Signaling Induces Survivin Gene Expression and Confers Resistance to Apoptosis in Human Breast Cancer Cells

S. Eschrich, J. Turkson, R. Jove, 2006, Clinical Cancer Research.

Managing a Large-Scale Multiomics Project: A Team Science Case Study in Proteogenomics.

Jamie K Teer, Eric A Welsh, Paul A Stewart, 2020, Methods in molecular biology.

Semiquantitative Computed Tomography Characteristics for Lung Adenocarcinoma and Their Association With Lung Cancer Survival.

Matthew B Schabath, Zhaoxiang Ye, Robert J Gillies, 2015, Clinical lung cancer.

Radiomics: the process and the challenges.

Andre Dekker, Yuhua Gu, Matthew B Schabath, 2012, Magnetic resonance imaging.

Smad4-mediated signaling inhibits intestinal neoplasia by inhibiting expression of β-catenin.

Joseph T. Roland, Xi Chen, T. Yeatman, 2012, Gastroenterology.

Smad 4 Depletion in Cultured Epithelial Cells Results in Increased-Catenin Expression and Activation of TOPFlash Activity

Joseph T. Roland, T. Yeatman, S. Eschrich, 2012 .

Empirically-derived synthetic populations to mitigate small sample sizes

Steven Eschrich, Michael J Schell, Anders Berglund, 2020, J. Biomed. Informatics.

Utilizing the genomically adjusted radiation dose (GARD) to personalize adjuvant radiotherapy in triple negative breast cancer management

Jacob G. Scott, S. Eschrich, J. Torres-Roca, 2019, EBioMedicine.

Phosphoproteomics Reveals MAPK Inhibitors Enhance MET- and EGFR-Driven AKT Signaling in KRAS-Mutant Lung Cancer

Bin Fang, Eric A Welsh, Eric B Haura, 2016, Molecular Cancer Research.

Metabolic Changes Are Associated with Melphalan Resistance in Multiple Myeloma.

S. Eschrich, A. Silva, O. Hampton, 2021, Journal of proteome research.

Toward a measure of classification complexity in gene expression signatures

Timothy J. Yeatman, Steven A. Eschrich, Vidya Kamath, 2008, 2008 30th Annual International Conference of the IEEE Engineering in Medicine and Biology Society.

Perturbation of the mutated EGFR interactome identifies vulnerabilities and resistance mechanisms

Bin Fang, Steven Eschrich, Giulio Superti-Furga, 2013, Molecular systems biology.

Characterizing Tyrosine Phosphorylation Signaling in Lung Cancer Using SH2 Profiling

S. Eschrich, B. Mayer, E. Haura, 2010, PloS one.

BVES regulates EMT in human corneal and colon cancer cells and is silenced via promoter methylation in human colorectal carcinoma.

Xi Chen, Frederick R Haselton, Steven Eschrich, 2011, The Journal of clinical investigation.

Phosphoproteomics identifies driver tyrosine kinases in sarcoma cell lines and tumors.

S. Eschrich, M. Bui, S. Altiok, 2012, Cancer research.

Integrated Systems and Technologies Phosphoproteomics Identi fi es Driver Tyrosine Kinases in Sarcoma Cell Lines and Tumors

S. Eschrich, M. Bui, S. Altiok, 2012 .

Integration of a Radiosensitivity Molecular Signature Into the Assessment of Local Recurrence Risk in Breast Cancer.

M. J. van de Vijver, S. Eschrich, M. Bollet, 2015, International journal of radiation oncology, biology, physics.

Radiosensitivity index predicts for survival with adjuvant radiation in resectable pancreatic cancer.

T. Strom, S. Eschrich, D. Coppola, 2015, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

A gene expression model of intrinsic tumor radiosensitivity: prediction of response and prognosis after chemoradiation.

David Boulware, Ji-Hyun Lee, T. Yeatman, 2009, International journal of radiation oncology, biology, physics.

Prediction of Radiation Sensitivity Using a Gene

T. Yeatman, S. Eschrich, R. Jove, 2005 .

Biomarkers to discern transplantation tolerance after allogeneic hematopoietic cell transplantation.

S. Eschrich, J. Lancaster, G. Bloom, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

A Predictive Risk Probability Approach for Microarray Data with Survival as an Endpoint

T. Yeatman, S. Eschrich, James J. Chen, 2008, Journal of biopharmaceutical statistics.

Tolerance Associated Gene Expression following Allogeneic Hematopoietic Cell Transplantation

S. Eschrich, M. Sarwal, G. Bloom, 2012, PloS one.

Epigenomic Characterization of Locally Advanced Anal Cancer: A Radiation Therapy Oncology Group 98-11 Specimen Study

S. Eschrich, J. Ajani, D. Shibata, 2014, Diseases of the colon and rectum.

APOSTL: An Interactive Galaxy Pipeline for Reproducible Analysis of Affinity Proteomics Data.

Paul A Stewart, Brent M Kuenzi, Adam L Borne, 2016, Journal of proteome research.

DNA Methylation Profiling across the Spectrum of HPV-Associated Anal Squamous Neoplasia

Jonathan M. Hernandez, S. Eschrich, D. Coppola, 2012, PloS one.

Test–Retest Reproducibility Analysis of Lung CT Image Features

Robert J. Gillies, Ying Liu, Hua Wang, 2014, Journal of Digital Imaging.

Tissue-specific RMA models to incrementally normalize Affymetrix GeneChip data

David A. Fenstermacher, Andrew M. Hoerter, Steven A. Eschrich, 2008, 2008 30th Annual International Conference of the IEEE Engineering in Medicine and Biology Society.

An Analysis of Nectin-4 (PVRL4) in Penile Squamous Cell Carcinoma

S. Eschrich, P. Johnstone, J. Chahoud, 2023, European Urology Open Science.

BASIC—ALIMENTARY TRACT Experimentally Derived Metastasis Gene Expression Profile Predicts Recurrence and Death in Patients With Colon Cancer

T. Yeatman, S. Eschrich, M. Washington, 2009 .

Proteometabolomics of Melphalan Resistance in Multiple Myeloma.

S. Eschrich, J. Guingab-Cagmat, E. Welsh, 2018, Methods in molecular biology.

Evaluating somatic tumor mutation detection without matched normal samples

S. Eschrich, W. D. Cress, J. Teer, 2017, Human Genomics.

Elucidation of a protein signature discriminating six common types of adenocarcinoma

Steven Eschrich, Gregory C Bloom, Domenico Coppola, 2007, International journal of cancer.

Generalization Methods in Bioinformatics

Nitesh V. Chawla, Lawrence O. Hall, Steven Eschrich, 2002, BIOKDD.

R. Gillies, S. Eschrich, H. Aerts, 2021, JNCI cancer spectrum.

A database of reaction monitoring mass spectrometry assays for elucidating therapeutic response in cancer

Richard Z. Liu, T. Yeatman, S. Eschrich, 2011, Proteomics. Clinical applications.

RSI: A genomic signature of radiosensitivity

Jacob G. Scott, S. Eschrich, J. Torres-Roca, 2016 .

Multivariate Feature Selection using Random Subspace Classifiers for Gene Expression Data

Lawrence O. Hall, Steven Eschrich, Timothy Yeatman, 2007, 2007 IEEE 7th International Symposium on BioInformatics and BioEngineering.

An Exact Test for Detecting Inconsistency in Readers Interpretation Over Time in Screening Mammograms

Steven Eschrich, Craig Beam, Ji-Hyun Lee, 2007, Biometrical journal. Biometrische Zeitschrift.

Peritumoral and intratumoral radiomic features predict survival outcomes among patients diagnosed in lung cancer screening

R. Gillies, S. Eschrich, O. Stringfield, 2020, Scientific Reports.

DRPPM-PATH-SURVEIOR: Plug-and-Play Survival Analysis of Pathway-level Signatures and Immune Components

S. Eschrich, S. Meshinchi, Mingxiang Teng, 2023, Research square.

Down‐regulation of Bax‐interacting factor‐1 in colorectal adenocarcinoma

T. Yeatman, S. Eschrich, D. Coppola, 2008, Cancer.

Fast accurate fuzzy clustering through data reduction

Lawrence O. Hall, Dmitry B. Goldgof, Steven Eschrich, 2003, IEEE Trans. Fuzzy Syst..

Effects of IFN-gamma and Stat1 on gene expression, growth, and survival in non-small cell lung cancer cells.

Eric B Haura, S. Eschrich, E. Haura, 2007, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

Correction: Quantitative Computed Tomographic Descriptors Associate Tumor Shape Complexity and Intratumor Heterogeneity with Prognosis in Lung Adenocarcinoma

P. Lambin, R. Gillies, S. Eschrich, 2021, PloS one.

Exploiting convergent phenotypes to derive a pan-cancer cisplatin response gene expression signature

Jacob G. Scott, S. Eschrich, J. Torres-Roca, 2023, NPJ precision oncology.

Exploiting convergent evolution to derive a pan-cancer cisplatin sensitivity gene expression signature

S. Eschrich, J. Torres-Roca, A. Dhawan, 2021, medRxiv.

HDAC inhibitors regulate claudin-1 expression in colon cancer cells through modulation of mRNA stability

X Chen, X. Chen, T. Yeatman, 2010, Oncogene.

Tumor-immune ecosystem dynamics define an individual Radiation Immune Score to predict pan-cancer radiocurability

S. Eschrich, J. Torres-Roca, J. Cleveland, 2021, Neoplasia.

Genome-wide host methylation profiling of anal and cervical carcinoma

S. Eschrich, J. Ajani, D. Shibata, 2021, PloS one.

Insig2 is associated with colon tumorigenesis and inhibits Bax‐mediated apoptosis

M. Gruidl, S. Eschrich, Hong-Gang Wang, 2008, International journal of cancer.

Abstract 5111: Integrative phospho-proteomic and genomic analyses identify AXL as a potential biomarker and therapeutic target for NRAS-mutated melanoma

S. Eschrich, K. Nathanson, K. Smalley, 2011 .

Feature selection for microarray data by AUC analysis

Lawrence O. Hall, Dmitry B. Goldgof, Juana Canul-Reich, 2008, 2008 IEEE International Conference on Systems, Man and Cybernetics.

Towards Data Driven RT Prescription: Integrating Genomics into RT Clinical Practice.

S. Eschrich, J. Torres-Roca, J. Scott, 2023, Seminars in radiation oncology.

The Radiosensitivity Index (RSI) Gene Signature Identifies Distinct Tumor Immune Microenvironment Characteristics Associated with Susceptibility to Radiotherapy.

S. Eschrich, J. Torres-Roca, J. Cleveland, 2022, International journal of radiation oncology, biology, physics.

Genomics and radiomics: Tools to see the unseen to personalize radiation therapy

S. Eschrich, J. Torres-Roca, M. Mills, 2019, Applied Radiation Oncology.

Radiosensitivity differences between liver metastases based on primary histology suggest implications for clinical outcomes following SBRT.

S. Eschrich, J. Torres-Roca, A. Berglund, 2016 .

42. Epigenomic profiling of anal cancer: does size matter? An RTOG 98-11 specimen study

S. Eschrich, J. Ajani, D. Coppola, 2013 .

Radiosensensitivity Index Shows Promise for Predicting Outcomes With Adjuvant Radiation in Resected Pancreatic Cancer Patients

T. Strom, S. Eschrich, D. Coppola, 2014 .

Radiosensitivity Molecular Signature Is Predictive of Overall Survival in Glioblastoma

S. Eschrich, J. Torres-Roca, J. Caudell, 2014 .

Techniques to produce and evaluate realistic multivariate synthetic data

J. Heine, S. Eschrich, M. Schell, 2021, bioRxiv.

PATH-SURVEYOR: pathway level survival enquiry for immuno-oncology and drug repurposing

S. Eschrich, Mingxiang Teng, Xuefeng Wang, 2023, BMC Bioinformatics.

An Assessment of the Penile Squamous Cell Carcinoma Surfaceome for Biomarker and Therapeutic Target Discovery

S. Eschrich, S. Rogatto, J. Chahoud, 2023, Cancers.

Deciphering Phenotypes from Protein Biomarkers for Translational Research with PIPER.

S. Eschrich, E. Haura, E. Welsh, 2023, Journal of proteome research.

Creating ensembles of classifiers

Nitesh V. Chawla, Lawrence O. Hall, Steven Eschrich, 2001, Proceedings 2001 IEEE International Conference on Data Mining.

Molecular and Cellular Pathobiology The Metabolomic Signature of Malignant Glioma Re fl ects Accelerated Anabolic Metabolism

S. Eschrich, R. Gillies, G. Bloom, 2012 .

Enabling Precision Medicine in Cancer Care Through a Molecular Data Warehouse: The Moffitt Experience.

B. Fridley, S. Eschrich, E. Siegel, 2021, JCO Clinical Cancer Informatics.

DNA microarrays and data analysis: an overview.

Steven Eschrich, T. Yeatman, S. Eschrich, 2004, Surgery.

Partial Least Squares (PLS) Applied to Medical Bioinformatics

Ravi Mathur, Jin-Woo Park, Steven Eschrich, 2011, Complex Adaptive Systems.

Informatics methods to enable sharing of quantitative imaging research data.

Fernando Boada, Andre Dekker, Charles Laymon, 2012, Magnetic resonance imaging.

Iterative feature perturbation method as a gene selector for microarray data

Juana Canul-Reich, Dmitry Goldgof, Steven Eschrich, 2009 .

The Prognostic Role of Human Papillomavirus and p16 Status in Penile Squamous Cell Carcinoma—A Systematic Review

S. Eschrich, C. Pettaway, J. Chahoud, 2023, Cancers.

Biomarkers to discern transplantation tolerance after allogeneic hematopoietic cell transplantation.

S. Eschrich, J. Lancaster, G. Bloom, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Association Between Computed Tomographic Features and Kirsten Rat Sarcoma Viral Oncogene Mutations in Patients With Stage I Lung Adenocarcinoma and Their Prognostic Value.

Y. Liu, J. Heine, R. Gillies, 2016, Clinical lung cancer.

Open Access Bmc Medical Genomics Exon Expression in Lymphoblastoid Cell Lines from Subjects with Schizophrenia before and after Glucose Deprivation

S. Eschrich, A. Daud, O. Fodstad, 2009 .

Experimentally derived metastasis gene expression profile predicts recurrence and death in patients with colon cancer.

T. Yeatman, S. Eschrich, M. Washington, 2010, Gastroenterology.

Transforming growth factor β-induced epithelial-to-mesenchymal signature predicts metastasis-free survival in non-small cell lung cancer

S. Eschrich, D. Shibata, E. Siegel, 2019, Oncotarget.

Comparing pure parallel ensemble creation techniques against bagging

Lawrence O. Hall, Kevin W. Bowyer, W. Philip Kegelmeyer, 2003, Third IEEE International Conference on Data Mining.

Informatics methods to enable sharing of quantitative imaging research data.

Matthew J. Oborski, J. Mountz, F. Fennessy, 2012, Magnetic resonance imaging.

Systems biology modeling of the radiation sensitivity network: a biomarker discovery platform.

S. Eschrich, Hongling Zhang, Haiyan Zhao, 2009, International journal of radiation oncology, biology, physics.

An expert system for evaluating risk in type-1 diabetes

Dmitry B. Goldgof, Jeffrey P. Krischer, Steven Eschrich, 2003, SMC'03 Conference Proceedings. 2003 IEEE International Conference on Systems, Man and Cybernetics. Conference Theme - System Security and Assurance (Cat. No.03CH37483).

A Comparison of Ensemble Creation Techniques

Lawrence O. Hall, Kevin W. Bowyer, W. Philip Kegelmeyer, 2004, Multiple Classifier Systems.

Phosphoproteomics identifies driver tyrosine kinases in sarcoma cell lines and tumors.

S. Eschrich, M. Bui, S. Altiok, 2012, Cancer research.

Filtering for improved gene selection on microarray data

Lawrence O. Hall, Dmitry B. Goldgof, Juana Canul-Reich, 2010, 2010 IEEE International Conference on Systems, Man and Cybernetics.

Automated registration and quantification of biophotonic mouse images using a whole body atlas

Dmitry B. Goldgof, Steven A. Eschrich, Michael Soria, 2009, Medical Imaging.

Towards a framework for analysis of biophotonic images of mouse models of cancer

Dmitry Goldgof, Vidya Kamath, Raul Argilagos, 2008, 2008 30th Annual International Conference of the IEEE Engineering in Medicine and Biology Society.

Noise-Based Feature Perturbation as a Selection Method for Microarray Data

Li Chen, Lawrence O. Hall, Dmitry B. Goldgof, 2007, ISBRA.

Learning from soft partitions of data: reducing the variance

Lawrence O. Hall, S. Eschrich, S. Eschrich, 2003, The 12th IEEE International Conference on Fuzzy Systems, 2003. FUZZ '03..

Soft partitions lead to better learned ensembles

Lawrence O. Hall, S. Eschrich, S. Eschrich, 2002, 2002 Annual Meeting of the North American Fuzzy Information Processing Society Proceedings. NAFIPS-FLINT 2002 (Cat. No. 02TH8622).

Personalizing Radiotherapy Prescription Dose Using Genomic Markers of Radiosensitivity and Normal Tissue Toxicity in Non-Small Cell Lung Cancer.

M. Kattan, S. Eschrich, J. Torres-Roca, 2020, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.